{"database": "lobbying", "table": "lobbying_activities", "rows": [[3190088, "d111ad3f-d63c-4f32-9f06-94b11635eb83", "Q2", "FORBES-TATE", 400976792, "PHRMA", 2024, "second_quarter", "CSP", "Issues related to Direct to Consumer (DTC) Advertising; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program.", "HOUSE OF REPRESENTATIVES,SENATE", 80000, null, 0, 0, "2024-07-13T01:35:32-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3190088"], "units": {}, "query_ms": 9.126921999268234, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}